Dynamiker Candida albicans IgM Assay is based on indirect Enzyme-linked Immunosorbent Assay (ELISA). It is used for the quantitative detection of Candida albicans anti-mannan IgM antibodies in human serum or plasma, offering a diagnostic reference for Candida albicans infection. The kit is intended for professional use only.
Dynamiker Biotechnology (Tianjin) Co., Ltd. was established in March 2014 with a registered capital of 46 million RMB. It is a high-tech enterprise and engaged in R&D, production and clinical application of early and rapid In-vitro diagnostics (IVD) of Invasive Fungal Disease (IFD). The headquarters of the company is located at the Sino-Singapore Tianjin Eco-city. Its R&D center is based at the Tianjin International Joint Academy of Biomedicine, Tianjin Binhai New Area.
Dyanmiker has established 6 technology platforms as certified by the ISO 13485. Those are used for preparations of invasive fungal biomarkers; their specific antibodies; the development and manufacturing of assays; the microbial automation; the microfluidics technology; and a R&D laboratory for breeding Asian horseshoe crabs as used for diagnostic applications. All of these platforms provide all-round support for our technology innovation and product transformation.
Dynamiker has developed over 10 novel products for the early diagnosis of IFD, 5 of which were approved by CFDA, 9 CE-marked, 4 registered in Turkey and 1 in Colombia. The registered products have showed very competitive over the international competitors.
In domestic, Dynamiker products entered into over 300 tertiary hospitals, such as Peking Union Medical College Hospital, Beijing 301 Military Hospital, Sir Run Run Shaw Hospital School of Medicine in Zhejiang University, Sichuan Provincial People's Hospital and First Affiliated Hospital of Sun Yat-Sen University, etc. At abroad, Dynamiker has distributors in over 20 countries such as UK, France, Italy, Spain and Brazil, etc.